{"transactions":[{"id":737399,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-15T21:49:24.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":18980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy."}],"balance_after":73164,"source":{"system":"sec-edgar","filing":"0001867172-26-000007","document":"wk-form4_1781560162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000186717226000007/wk-form4_1781560162.xml","form_type":"4"}},{"id":740104,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T21:08:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001867172-26-000006","document":"form4-06122026_090629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000186717226000006/form4-06122026_090629.xml","form_type":"4"}},{"id":761232,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-05-27T21:29:11.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":212,"price":309.5142,"value":65617.0104,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001867172-26-000004","document":"wk-form4_1779917348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000186717226000004/wk-form4_1779917348.xml","form_type":"4"}},{"id":945548,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T01:00:28.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":14761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026."}],"balance_after":14761,"derivative":{"exercise_price":7.08,"expiration_date":"2036-01-02","underlying":"Ordinary Shares","underlying_shares":14761},"source":{"system":"sec-edgar","filing":"0001867172-26-000002","document":"form4-01062026_080113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000186717226000002/form4-01062026_080113.xml","form_type":"4"}},{"id":945547,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:28.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":19880,"source":{"system":"sec-edgar","filing":"0001867172-26-000002","document":"form4-01062026_080113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000186717226000002/form4-01062026_080113.xml","form_type":"4"}},{"id":1109905,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:25:41.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":0.6,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-25-011786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325011786/form4.xml","form_type":"4"}},{"id":1136679,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T23:44:55.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":22750,"derivative":{"exercise_price":18.19,"expiration_date":"2035-05-20","underlying":"Ordinary Shares","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001651308-25-000088","document":"wk-form4_1747957486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000088/wk-form4_1747957486.xml","form_type":"4"}},{"id":1136678,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T23:44:55.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":10985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":56940,"source":{"system":"sec-edgar","filing":"0001651308-25-000088","document":"wk-form4_1747957486.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000088/wk-form4_1747957486.xml","form_type":"4"}},{"id":1189457,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-27T21:17:20.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option will vest in three equal installments on each of March 25, 2026, March 25, 2027 and March 25, 2028."}],"balance_after":25000,"derivative":{"exercise_price":9.2,"expiration_date":"2035-03-25","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-009117","document":"form4-03272025_090317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925009117/form4-03272025_090317.xml","form_type":"4"}},{"id":1189456,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-27T21:17:20.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit (\"RSU\") award. The RSUs will vest in three equal installments on each of March 25, 2026, March 25, 2027 and March 25, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001415889-25-009117","document":"form4-03272025_090317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925009117/form4-03272025_090317.xml","form_type":"4"}},{"id":1472178,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:50:20.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 20, 2025, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":2.69,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-24-012903","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324012903/form4.xml","form_type":"4"}},{"id":1486088,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-07T20:57:19.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":34151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":34151,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":34151},"source":{"system":"sec-edgar","filing":"0001651308-24-000059","document":"wk-form4_1717793831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000059/wk-form4_1717793831.xml","form_type":"4"}},{"id":1486087,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-07T20:57:19.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":16341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":45955,"source":{"system":"sec-edgar","filing":"0001651308-24-000059","document":"wk-form4_1717793831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000059/wk-form4_1717793831.xml","form_type":"4"}},{"id":1842079,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T20:22:34.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 27, 2024, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":3.19,"expiration_date":"2024-06-27","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-23-014172","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323014172/form4.xml","form_type":"4"}},{"id":1848705,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-20T23:01:29.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":26975,"derivative":{"exercise_price":16.41,"expiration_date":"2033-06-14","underlying":"Ordinary Shares","underlying_shares":26975},"source":{"system":"sec-edgar","filing":"0001651308-23-000098","document":"wf-form4_168730207645417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000098/wf-form4_168730207645417.xml","form_type":"4"}},{"id":1848704,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T23:01:29.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":29614,"source":{"system":"sec-edgar","filing":"0001651308-23-000098","document":"wf-form4_168730207645417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000098/wf-form4_168730207645417.xml","form_type":"4"}},{"id":2221754,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-24T21:38:01.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":34645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":34645,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":34645},"source":{"system":"sec-edgar","filing":"0001651308-22-000106","document":"wf-form4_165610666171630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000106/wf-form4_165610666171630.xml","form_type":"4"}},{"id":2221753,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-24T21:38:01.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":16692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share unites were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":16692,"source":{"system":"sec-edgar","filing":"0001651308-22-000106","document":"wf-form4_165610666171630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000106/wf-form4_165610666171630.xml","form_type":"4"}},{"id":2236319,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:23:37.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":19872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 9, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":19872,"derivative":{"exercise_price":8.56,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":19872},"source":{"system":"sec-edgar","filing":"0001062993-22-014657","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322014657/form4.xml","form_type":"4"}},{"id":2359301,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-03-02T22:10:18.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":22581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":22581,"derivative":{"exercise_price":16.22,"expiration_date":"2032-02-27","underlying":"Ordinary Shares","underlying_shares":22581},"source":{"system":"sec-edgar","filing":"0001651308-22-000034","document":"wf-form4_164625896762526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000034/wf-form4_164625896762526.xml","form_type":"4"}},{"id":2661495,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38027,"kind":"person","name":"Riva Alessandro","position":1,"cik":"0001867172","reported_name":"Riva Alessandro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-21T20:31:28.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":19872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":19872,"derivative":{"exercise_price":20,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19872},"source":{"system":"sec-edgar","filing":"0001192482-21-000557","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000119248221000557/edgar.xml","form_type":"4"}}]}